#

Healthcare

: 26
Regentis technology regenerates damaged or diseased tissue including inflamed cartilage and bone / Photo: U.P.SD / Shutterstock
Small Caps·
Micro cap implant maker Regentis adds 500% after canceling secondary offering
The announcement of a peace deal between the US and Iran could send the US stock market tumbling, warns Nomura strategist / Photo: X / NYSE
News·
Peace paradox: why does Nomura strategist expect US stocks to fall because of the Iran deal?
An outbreak of a dangerous hantavirus infection occurred on the cruise liner MV Hondius. Passengers were evacuated and the liner arrived at the port of Rotterdam on May 18. Photo: Chris McGrath/Getty Images
Review·
WHO reports hantavirus and a dangerous Ebola outbreak. Will this set off a new vaccine race?
The S&P 500 will include securities of life sciences software developer Veeva Systems / Photo: X / NYSE
News·
There will be a new stock in the S&P 500, it has already soared 11%. Is it worth buying?
Founded in 2012, New York-based National Healthcare Properties was managed by Healthcare Trust Advisors until its restructuring in 2024 / Photo: National Healthcare Properties
News·
National Healthcare IPO: fund investing in senior campuses goes public
OpenAI is close to closing the first phase of a new investment round that could bring it more than $100 billion / Photo: Matthew Nichols1 / Shutterstock
Review·
Highlights for the morning: OpenAI prepares a round over $100 billion, Meta returns to smartwatches
Investors are waiting for the FOMC member to assess inflationary processes and their impact on economic growth / Photo: Stockinasia / Shutterstock
News·
Morning in New York: Statistics and Fed rhetoric will set the tone for trading
IPO of a company developing treatments for eye diseases/Photo: laowaika
News·
SpyGlass Pharma IPO: developer of eye disease therapy device goes public
The key event of the day will be the decisions of the first Fed meeting in 2026 / Photo: Rob Crandall / Shutterstock
News·
Morning in New York: Fed signals in focus
Highlights for the morning: US duties on Irans partners, the OpenAI deal and Venezuelas market surge
Review·
Highlights for the morning: US duties on Iran's partners, the OpenAI deal and Venezuela's market surge
Morning in New York: Stock market players capitalize on post-holiday momentum
News·
Morning in New York: Stock market players capitalize on post-holiday momentum
Sanofi is expanding its vaccine business. It will buy Dynavax for $2.2 billion
News·
Sanofi is expanding its vaccine business. It will buy Dynavax for $2.2 billion
Load more